Literature DB >> 30821119

The role of microRNAs in the healing of diabetic ulcers.

Golnaz Goodarzi1, Mahmood Maniati2, Durdi Qujeq3,4,5,6.   

Abstract

MicroRNAs (miRNAs) are small protected molecules with a length of 18 to 25 nucleotides. Many studies have recently been conducted on miRNAs, illustrating their role in regulating many biological, physiological, and pathological activities, such as maintaining cellular signalling and regulating cellular pathways. The main role of miRNAs is to regulate the expression of genes after translation, which can lead to the destruction or suppression of translation by binding to mRNAs. As any change in the regulation of miRNAs is associated with several physiological abnormalities, such as type 2 diabetes and its complications, these molecules can be used for therapeutic purposes or as biomarkers for the diagnosis of diseases such as diabetes and its complications. In this review article, we will discuss important findings about the miRNAs and the role of these molecules in different phases of the wound-healing process of chronic wounds, especially diabetic ulcer.
© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes; healing; miRNAs; ulcer; wound

Mesh:

Substances:

Year:  2019        PMID: 30821119      PMCID: PMC7949391          DOI: 10.1111/iwj.13070

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  162 in total

Review 1.  MicroRNAs as novel players in skin development, homeostasis and disease.

Authors:  M R Schneider
Journal:  Br J Dermatol       Date:  2011-11-04       Impact factor: 9.302

2.  Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney.

Authors:  Mohammad Reza Alipour; Amir Mahdi Khamaneh; Nasibeh Yousefzadeh; Daryoush Mohammad-nejad; Farhad Ghadiri Soufi
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

Review 3.  miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'.

Authors:  Chiranjib Chakraborty; C George Priya Doss; Sanghamitra Bandyopadhyay
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

Review 4.  Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus.

Authors:  Sundararajan Srikanth; Prakash Deedwania
Journal:  Cardiol Clin       Date:  2011-02       Impact factor: 2.213

Review 5.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Chandan K Sen
Journal:  Methods Mol Biol       Date:  2013

6.  miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway.

Authors:  Fen Liu; Yong Li; Rong Jiang; Cheng Nie; Zhenguo Zeng; Ning Zhao; Caixue Huang; Qiang Shao; Chengzhi Ding; Cheng Qing; Liang Xia; Erming Zeng; Kejian Qian
Journal:  Exp Lung Res       Date:  2015-06       Impact factor: 2.459

7.  MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment.

Authors:  Anca Dorhoi; Marco Iannaccone; Maura Farinacci; Kellen C Faé; Jörg Schreiber; Pedro Moura-Alves; Geraldine Nouailles; Hans-Joachim Mollenkopf; Dagmar Oberbeck-Müller; Sabine Jörg; Ellen Heinemann; Karin Hahnke; Delia Löwe; Franca Del Nonno; Delia Goletti; Rosanna Capparelli; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  MicroRNA dysregulation in diabetic ischemic heart failure patients.

Authors:  Simona Greco; Pasquale Fasanaro; Serenella Castelvecchio; Yuri D'Alessandra; Diego Arcelli; Marisa Di Donato; Alexis Malavazos; Maurizio C Capogrossi; Lorenzo Menicanti; Fabio Martelli
Journal:  Diabetes       Date:  2012-03-16       Impact factor: 9.461

9.  Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3.

Authors:  Shu Meng; Jiatian Cao; Xiaoping Zhang; Yuqi Fan; Lu Fang; Changqian Wang; Zhongwei Lv; Da Fu; Yigang Li
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

10.  miR-27b represses migration of mouse MSCs to burned margins and prolongs wound repair through silencing SDF-1a.

Authors:  Mu-Han Lü; Chang-Jiang Hu; Ling Chen; Xi Peng; Jian Chen; Jiong-Yu Hu; Miao Teng; Guang-Ping Liang
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more
  4 in total

Review 1.  The role of microRNAs in the healing of diabetic ulcers.

Authors:  Golnaz Goodarzi; Mahmood Maniati; Durdi Qujeq
Journal:  Int Wound J       Date:  2019-02-28       Impact factor: 3.315

2.  Enhanced Expression of miR-34c in Peripheral Plasma Associated with Diabetic Foot Ulcer in Type 2 Diabetes Patients.

Authors:  Tingting Wu; Dandan Xie; Xiaotong Zhao; Murong Xu; Li Luo; Datong Deng; Mingwei Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-15       Impact factor: 3.168

3.  Down-Regulation of miR-138 Alleviates Inflammatory Response and Promotes Wound Healing in Diabetic Foot Ulcer Rats via Activating PI3K/AKT Pathway and hTERT.

Authors:  Jian Wang; Xiaodan Zhao; Guichang Tian; Xiaochao Liu; Chengyan Gui; Lin Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-14       Impact factor: 3.249

4.  Wound dressings incorporating microRNAs: Innovative therapy for diabetic wound treatment.

Authors:  Mohammad Hasan Soheilifar; Nastaran Masoudi-Khoram
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.